EMPATECH MET

Description

EMPATECH MET 12.5/500 is a dual-acting oral antidiabetic medication designed for the effective management of Type 2 Diabetes Mellitus (T2DM). It combines Empagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor, with Metformin Hydrochloride, a first-line biguanide agent. This combination helps in lowering blood glucose levels by improving insulin sensitivity and promoting glucose excretion through urine. It is especially beneficial for patients who do not achieve adequate glycemic control through monotherapy or lifestyle changes alone. Key Ingredients Empagliflozin (12.5 mg): An SGLT2 inhibitor that reduces blood sugar by preventing glucose reabsorption in the kidneys, promoting its elimination through urine. It also contributes to weight loss and blood pressure reduction. Metformin Hydrochloride (500 mg): A biguanide antidiabetic that works by decreasing hepatic glucose production, improving insulin sensitivity, and enhancing peripheral glucose uptake and utilization. Key Benefits Provides comprehensive blood sugar control through two complementary mechanisms Promotes weight reduction and may support lower blood pressure Reduces the risk of cardiovascular events in diabetic patients with heart disease Helps in preventing complications related to poorly controlled diabetes Improves glycemic control with a lower risk of hypoglycemia compared to other agents Aids in urinary glucose excretion, reducing the glucose load in the body How Does It Work? EMPATECH MET 12.5/500 delivers dual-action benefits: Empagliflozin inhibits the SGLT2 protein in the kidneys, responsible for reabsorbing glucose back into the blood. By blocking this action, glucose is excreted in the urine, thereby lowering blood sugar levels naturally. Metformin decreases glucose production in the liver and improves the body's response to insulin. It also helps the muscles absorb glucose more efficiently and reduces the amount of sugar absorbed from the food you eat. Together, these mechanisms provide synergistic glucose-lowering effects, offering better diabetes control than monotherapy. Directions for Use Take EMPATECH MET 12.5/500 as prescribed by your physician, usually once or twice daily. It should be taken with meals to minimize gastrointestinal side effects. Swallow the tablet whole with a glass of water — do not crush or chew. Maintain a consistent routine for maximum effectiveness. Do not skip doses or discontinue use without consulting your doctor. Combine with a balanced diet, regular exercise, and routine blood glucose monitoring for best results. Side Effects Most people tolerate EMPATECH MET 12.5/500 well, but some may experience mild to moderate side effects: Common Side Effects: Frequent urination Increased thirst Nausea or vomiting Diarrhea Headache Genital or urinary tract infections (due to sugar in the urine) Rare but Serious Side Effects: Lactic acidosis (very rare; watch for weakness, unusual muscle pain, or trouble breathing) Severe dehydration Hypoglycemia (when used with other antidiabetic drugs) Ketoacidosis (extremely rare but serious; symptoms include nausea, vomiting, abdominal pain, confusion) Seek immediate medical attention if you notice symptoms of allergic reaction, unusual fatigue, or difficulty breathing.